Jed C. Kaminetsky MD graduated from NYU School of Medicine and completed his urologic residency at the same institution. He has been a faculty member for his entire professional career. Considered a thought leader in various aspects of men’s health, Dr. Kaminetsky’s expertise includes benign prostatic hypertrophy (BPH), voiding dysfunction, and sexual dysfunction diagnoses of ED, hypogonadism, and Peyronie’s disease.

Dr Kaminetsky has performed over 3,500 no scalpel vasectomies in his office. In addition to his clinical practice, Dr. Kaminetsky is the founder of Manhattan Medical Research where he has been a principal investigator in over 100 clinical trials, authored over 50 publications and has presented at national and international meetings.

He has been an early adopter and assisted in the development of many urologic treatments including Rezum™, I-Tind, Urolift®, GreenLight™  Laser Therapy, Testopel®, Xiaflex® for Peyronie’s disease and shock wave for erectile enhancement.